Amica Mutual Insurance’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.97M | Hold |
23,030
| – | – | 0.34% | 74 |
|
|
2025
Q4 | $4.59M | Buy |
23,030
+867
| +4% | +$157K | 0.4% | 59 |
|
|
2025
Q3 | $3.47M | Hold |
22,163
| – | – | 0.32% | 68 |
|
|
2025
Q2 | $3.36M | Hold |
22,163
| – | – | 0.32% | 67 |
|
|
2025
Q1 | $3.34M | Hold |
22,163
| – | – | 0.37% | 67 |
|
|
2024
Q4 | $4.09M | Hold |
22,163
| – | – | 0.42% | 60 |
|
|
2024
Q3 | $4.37M | Hold |
22,163
| – | – | 0.42% | 63 |
|
|
2024
Q2 | $4.58M | Buy |
22,163
+6,313
| +40% | +$1.43M | 0.46% | 62 |
|
|
2024
Q1 | $4.29M | Hold |
15,850
| – | – | 0.44% | 64 |
|
|
2023
Q4 | $3.75M | Hold |
15,850
| – | – | 0.4% | 67 |
|
|
2023
Q3 | $3.11M | Hold |
15,850
| – | – | 0.37% | 72 |
|
|
2023
Q2 | $3.33M | Sell |
15,850
-1,378
| -8% | -$274K | 0.38% | 72 |
|
|
2023
Q1 | $3.48M | Sell |
17,228
-16,986
| -50% | -$3.85M | 0.39% | 73 |
|
|
2022
Q4 | $7.46M | Sell |
34,214
-1,408
| -4% | -$307K | 0.94% | 30 |
|
|
2022
Q3 | $7.01M | Buy |
35,622
+6,425
| +22% | +$1.39M | 0.99% | 29 |
|
|
2022
Q2 | $6.25M | Buy |
29,197
+3,447
| +13% | +$842K | 0.79% | 43 |
|
|
2022
Q1 | $7.31M | Buy |
25,750
+10,935
| +74% | +$3.37M | 0.86% | 36 |
|
|
2021
Q4 | $5.58M | Buy |
14,815
+2,482
| +20% | +$964K | 0.47% | 62 |
|
|
2021
Q3 | $5.09M | Hold |
12,333
| – | – | 0.53% | 70 |
|
|
2021
Q2 | $4.56M | Sell |
12,333
-7,005
| -36% | -$2.34M | 0.48% | 68 |
|
|
2021
Q1 | $5.61M | Sell |
19,338
-1,108
| -5% | -$308K | 0.64% | 50 |
|
|
2020
Q4 | $5.11M | Hold |
20,446
| – | – | 0.56% | 53 |
|
|
2020
Q3 | $4.63M | Sell |
20,446
-5,461
| -21% | -$1.13M | 0.55% | 54 |
|
|
2020
Q2 | $4.52M | Hold |
25,907
| – | – | 0.55% | 50 |
|
|
2020
Q1 | $3.27M | Buy |
25,907
+7,510
| +41% | +$1.13M | 0.45% | 61 |
|
|
2019
Q4 | $2.81M | Hold |
18,397
| – | – | 0.37% | 69 |
|
|
2019
Q3 | $2.44M | Buy |
18,397
+3,859
| +27% | +$517K | 0.31% | 90 |
|
|
2019
Q2 | $2.06M | Hold |
14,538
| – | – | 0.26% | 99 |
|
|
2019
Q1 | $2.11M | Hold |
14,538
| – | – | 0.26% | 97 |
|
|
2018
Q4 | $1.65M | Hold |
14,538
| – | – | 0.21% | 115 |
|
|
2018
Q3 | $1.96M | Hold |
14,538
| – | – | 0.2% | 129 |
|
|
2018
Q2 | $1.63M | Hold |
14,538
| – | – | 0.2% | 149 |
|
|
2018
Q1 | $1.55M | Hold |
14,538
| – | – | 0.19% | 156 |
|
|
2017
Q4 | $1.59M | Hold |
14,538
| – | – | 0.16% | 168 |
|
|
2017
Q3 | $1.57M | Hold |
14,538
| – | – | 0.14% | 196 |
|
|
2017
Q2 | $1.47M | Hold |
14,538
| – | – | 0.13% | 197 |
|
|
2017
Q1 | $1.31M | Hold |
14,538
| – | – | 0.12% | 214 |
|
|
2016
Q4 | $1.11M | Buy |
+14,538
| New | +$1.1M | 0.1% | 249 |
|
Other funds holding CRL
VCM
VPM
Amica Mutual Insurance's CRL Position: Q1 2026 in Review
Amica Mutual Insurance held its Charles River Laboratories (CRL) position steady in Q1 2026 at 23,030 shares worth $3.97M. The position accounts for 0.34% of the portfolio, ranked #74.
Amica Mutual Insurance first reported a position in CRL in Q4 2016 and has held it in 38 quarters since. The position peaked at $7.46M in Q4 2022. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Amica Mutual Insurance held 23,030 shares of Charles River Laboratories worth $3.97M as of Q1 2026.
- Amica Mutual Insurance left its Charles River Laboratories share count unchanged in Q1 2026.
- Charles River Laboratories made up 0.34% of Amica Mutual Insurance's portfolio in Q1 2026, its #74 holding.
- Amica Mutual Insurance first reported a position in Charles River Laboratories in Q4 2016 and has held it in 38 quarters since.
- Amica Mutual Insurance's Charles River Laboratories position peaked at $7.46M in Q4 2022.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Amica Mutual Insurance's 13F filing for Q1 2026, filed 6 May 2026.